Ken Griffin acquired 88.5 Thousand Apellis Pharmaceuticals shares worth $1.58 Million. That's 0.00% of their equity portfolio (2536th largest holding). The first Apellis Pharmaceuticals trade was made in Q2 2018. Since then Ken Griffin bought shares 36 more times and sold shares on 32 occasions. The investor's estimated purchase price is $4.44 Million, resulting in a loss of 64%.